CVS Health (NYSE:CVS) PT Lowered to $74.00 at The Goldman Sachs Group
CVS Health (NYSE:CVS – Free Report) had its price target lowered by The Goldman Sachs Group from $85.00 to $74.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the pharmacy operator’s stock. A number of other research analysts have also commented on CVS. Mizuho cut their target […]